Chandra Bhagat Pharma Limited

About

Chandra Bhagat Pharma Limited, a pharmaceutical company, markets pharmaceutical critical care and health care products in India and internationally. The company offers pharmaceutical formulations, including intravenous and intramuscular injections, oral solids, tablets, capsules, liquid orals, syrup suspensions, injectable liquids, powders, lyophilized ampoules, vials, prefilled syringes, and small and large volume parenteral for various therapeutic categories, such as anti-cancer, anti-infective, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to hospitals and health care centers through its own distribution networks and sales force under its own brand. It also promotes and markets specialty chemicals, intermediates, and active pharmaceuticals ingredients. In addition, the company manufactures pharmaceuticals. It exports its products. Chandra Bhagat Pharma Limited was founded in 1944 and is based in Mumbai, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in — check back soon.

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	116.00	89.00	221.00	120.00	94.00	71.00	94.00	106.00	97.00	90.00	80.00	61.00
Expenses	112.00	88.00	228.00	116.00	91.00	67.00	91.00	102.00	92.00	85.00	76.00	58.00
Operating Profit	4.00	1.00	-7.00	3.00	3.00	4.00	3.00	5.00	5.00	4.00	3.00	3.00
OPM %	3.30	0.70	-3.20	2.80	3.00	5.00	3.30	4.30	4.70	4.90	4.30	4.90
Other Income	3.00	3.00	11.00	0.00	2.00	0.00	0.00	0.00	1.00	0.00	0.00	0.00
Interest	2.00	2.00	1.00	2.00	3.00	4.00	3.00	4.00	4.00	4.00	3.00	2.00
Depreciation	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	4.00	1.00	2.00	1.00	1.00	0.00	0.00	1.00	2.00	1.00	1.00	1.00
Tax %	26.00	26.00	33.00	22.00	27.00	32.00	26.00	22.00	33.00	27.00	51.00	39.00
Net Profit	3.00	1.00	2.00	1.00	1.00	0.00	0.00	1.00	1.00	1.00	0.00	0.00
EPS in Rs	4.04	1.14	2.03	1.21	1.06	0.25	0.41	10.29	24.64	15.79	8.37	10.29
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	8.00	8.00	8.00	8.00	8.00	8.00	8.00	0.67	0.42	0.42	0.42	0.42
Reserves	26.00	22.00	21.00	20.00	19.00	18.00	18.00	14.00	8.00	7.00	6.00	6.00
Borrowings	17.00	21.00	16.00	19.00	21.00	27.00	30.00	31.00	22.00	22.00	28.00	28.00
Other Liabilities	45.00	51.00	56.00	14.00	25.00	19.00	19.00	37.00	28.00	26.00	10.00	8.00
Total Liabilities	94.00	102.00	102.00	61.00	72.00	72.00	75.00	83.00	58.00	56.00	44.00	42.00
Fixed Assets	3.00	3.00	3.00	1.00	0.00	0.00	0.00	0.00	1.00	1.00	1.00	1.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2.00	0.00	0.00	0.00	0.00	0.00	1.00	4.00	1.00	5.00	0.00	0.00
Other Assets	90.00	99.00	99.00	60.00	72.00	71.00	74.00	78.00	56.00	51.00	44.00	41.00
Total Assets	94.00	102.00	102.00	61.00	72.00	72.00	75.00	83.00	58.00	56.00	44.00	42.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity	9.00	-6.00	6.00	5.00	12.00	8.00	-7.00	4.00	-6.00	-9.00
Cash from Investing Activity	0.00	-1.00	-2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activity	-6.00	2.00	-6.00	-4.00	-10.00	-6.00	7.00	-4.00	7.00	8.00
Net Cash Flow	2.00	-4.00	-1.00	1.00	3.00	2.00	0.00	0.00	0.00	-1.00
Free Cash Flow	8.00	-6.00	4.00	5.00	12.00	8.00	-7.00	4.00	-6.00	-9.00
CFO/OP %	250.00	-805.00	-94.00	164.00	440.00	229.00	-238.00	98.00	-129.00	-200.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	171.00	148.00	65.00	25.00	58.00	80.00	54.00	90.00	67.00	80.00	66.00	71.00
Inventory Days	18.00	3.00	15.00	100.00	153.00	215.00	187.00	174.00	145.00	133.00	123.00	177.00
Days Payable	124.00	45.00	23.00	11.00	12.00	79.00	53.00	117.00	69.00	81.00	33.00	43.00
Cash Conversion Cycle	65.00	107.00	57.00	114.00	199.00	216.00	188.00	146.00	143.00	132.00	156.00	205.00
Working Capital Days	77.00	101.00	36.00	75.00	104.00	177.00	148.00	83.00	138.00	125.00	134.00	166.00
ROCE %	12.00	6.00	8.00	7.00	9.00	7.00	7.00	13.00	17.00	15.00	10.00	10.00

Shareholding Pattern

% holding — latest first

Holder	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Sep 2023	Mar 2023	Sep 2022	Mar 2022	Sep 2021	Mar 2021	Sep 2020
Promoters	73.02	72.19	71.20	69.29	68.77	68.69	68.24	69.09	70.11	71.80	71.80	70.42
FIIs	0.00	0.61	0.61	0.48	1.33	1.33	0.85	0.85	0.00	0.00	0.00	0.00
DIIs	0.00	0.00	0.00	0.00	0.89	0.89	0.00	0.00	0.00	0.00	0.00	0.00
Public	26.99	27.20	28.18	30.23	29.02	29.09	30.91	30.07	29.89	28.20	28.20	29.58
No. of Shareholders	280	301	316	315	152	134	146	126	126	90	106	156

Corporate Actions

No corporate actions recorded.

Announcements

5 filings

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 3 Sep
03 Sep 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
01 Sep 2026 1 Sep - 23rd AGM held on 1 Sep 2026; proposed authorised capital increase and up to 66 lakh warrants.
Corrigendum Of AGM Notice
20 Aug 2026 20 Aug - Corrigendum to AGM notice updates link for 66 lakh convertible warrants compliance certificate before 1 Sept 2026 AGM.
Notice Of Shareholders Meeting Scheduled On 1St September, 2026
06 Aug 2026 6 Aug - AGM on 1 Sep 2026; seeks capital hike to Rs 15 crore and 66 lakh warrants at Rs 44.
Reg. 34 (1) Annual Report. 6 Aug
06 Aug 2026